Lipin 1 is a bifunctional
protein that is a transcriptional regulator and has
phosphatidic acid (PA)
phosphohydrolase activity, which dephosphorylates PA to generate
diacylglycerol. Human
lipin 1 mutations lead to episodic
rhabdomyolysis, and some affected patients exhibit cardiac abnormalities, including exercise-induced cardiac dysfunction and cardiac
triglyceride accumulation. Furthermore,
lipin 1 expression is deactivated in failing heart, but the effects of
lipin 1 deactivation in myocardium are incompletely understood. We generated mice with cardiac-specific
lipin 1 KO (cs-Lpin1-/-) to examine the intrinsic effects of
lipin 1 in the myocardium. Cs-Lpin1-/- mice had normal systolic cardiac function but mild
cardiac hypertrophy. Compared with littermate control mice, PA content was higher in cs-Lpin1-/- hearts, which also had an unexpected increase in
diacylglycerol and
triglyceride content. Cs-Lpin1-/- mice exhibited diminished cardiac
cardiolipin content and impaired mitochondrial respiration rates when provided with
pyruvate or
succinate as metabolic substrates. After transverse aortic constriction-induced pressure overload, loss of
lipin 1 did not exacerbate
cardiac hypertrophy or dysfunction. However, loss of
lipin 1 dampened the cardiac ionotropic response to
dobutamine and exercise endurance in association with reduced
protein kinase A signaling. These data suggest that loss of
lipin 1 impairs cardiac functional reserve, likely due to effects on glycerolipid homeostasis, mitochondrial function, and
protein kinase A signaling.